The Role of Central Melanocortins in Cachexia

作者: Daniel L. Marks

DOI: 10.1007/978-1-60327-139-4_4

关键词: Melanocortin receptorCachexiaWeight lossInternal medicineMedicineAnimal dataMelanocortinCentral melanocortin systemEndocrinologyAnorexiaAppetite

摘要: Cachexia is a clinical syndrome of wasting that accompanies many chronic diseases including cancer, renal failure, and heart failure. This condition marked by an increase in energy expenditure preferential loss lean body mass, creating striking catabolic state. contrasts with starvation, state which decreases muscle mass maintained while fat stores are consumed. In contrast, cachexia accompanied paradoxical anorexia occurs despite ongoing weight negative calorie balance. appetite significant component the decreased quality life experienced patients cachexia. Few treatments have proved to be benefit suffering from One new treatment shows promise pharmacologic blockade central melanocortin system. The importance this system maintaining normal humans highlighted finding disordered signaling results early-onset morbid obesity dramatic increases humans. Emerging evidence suggests blocking via antagonists type 4 receptor (MC4R) may restore subjects caused variety underlying disorders. review will focus on current pathophysiologic mechanisms involved outline pathway as pertaining these summarize early animal data using MC4R treat

参考文章(77)
Kosok A, Rudenstein R, Cohan Gr, Simons G, Turner Jl, Guenter P, Muurahainen N, Relationships among nutritional status, disease progression, and survival in HIV infection. Journal of Acquired Immune Deficiency Syndromes. ,vol. 6, pp. 1130- 1138 ,(1993)
Long Cn, Brobeck, Tepperman J, Experimental Hypothalamic Hyperphagia in the Albino Rat. Yale Journal of Biology and Medicine. ,vol. 15, pp. 831- 853 ,(1943)
Christian Vaisse, Karine Clement, Bernard Guy-Grand, Philippe Froguel, A frameshift mutation in human MC4R is associated with a dominant form of obesity Nature Genetics. ,vol. 20, pp. 113- 114 ,(1998) , 10.1038/2407
Stephen J. Wigmore, Kenneth C. H. Fearon, Jean P. Maingay, James A. Ross, Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clinical Science. ,vol. 92, pp. 215- 221 ,(1997) , 10.1042/CS0920215
Kent Lundholm, Richard Chizzonite, Lyle L. Moldawer, Christina Lönnroth, Barbara Sherry, Johan Gelin, Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Research. ,vol. 51, pp. 415- 421 ,(1991)
Giles S.H. Yeo, I. Sadaf Farooqi, Shiva Aminian, David J. Halsall, Richard G. Stanhope, Stephen O'Rahilly, A frameshift mutation in MC4R associated with dominantly inherited human obesity Nature Genetics. ,vol. 20, pp. 111- 112 ,(1998) , 10.1038/2404
Mary M. Hagan, Paul A. Rushing, Laurel M. Pritchard, Michael W. Schwartz, Alison M. Strack, Lex H. T. Van der Ploeg, Stephen C. Woods, Randy J. Seeley, Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade. American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 279, ,(2000) , 10.1152/AJPREGU.2000.279.1.R47
C. R. Plata-Salaman, J. P. Borkoski, Chemokines/intercrines and central regulation of feeding American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 266, ,(1994) , 10.1152/AJPREGU.1994.266.5.R1711
Carlos R. Plata-Salamán, Gayatri Sonti, Jeffrey P. Borkoski, Charlie D. Wilson, Jarlath M.H. Ffrench-Mullen, Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiology & Behavior. ,vol. 60, pp. 867- 875 ,(1996) , 10.1016/0031-9384(96)00148-5